Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
22 Feb 2025
New Oral Regimens Shorten Rifampin-Resistant Tuberculosis Treatment
New 9-month, all-oral regimens for fluoroquinolone-susceptible, rifampin-resistant tuberculosis are as effective as the standard longer-duration therapy.
22 Feb 2025
Breakthrough Blood Test Offers Hope for Early Pancreatic Cancer Detection
A new blood test, PAC-MANN, shows promise for early detection of pancreatic cancer, improving treatment options and survival rates.
22 Feb 2025
A New Way to Improve Melanoma Immunotherapy
Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.
22 Feb 2025
New Research in Pulmonary Fibrosis Could Reverse Lung Scarring
Pulmonary fibrosis (PF), a severe form of lung disease, often leads to irreversible lung damage, and macrophages play a critical role in its progression.
21 Feb 2025
GERD Symptoms Linked to Worse RA Outcomes
Gastroesophageal (GE) symptoms, such as acid reflux and heartburn, are significantly associated with higher disease activity in patients with rheumatoid arthritis (RA), according to a new study.
21 Feb 2025
Hidradenitis Suppurativa Long-Term Data Shows Lasting Relief
Long-term data reveal that bimekizumab, a dual IL-17A and IL-17F inhibitor, provides sustained symptom control for patients with hidradenitis suppurativa (HS).
21 Feb 2025
Degenerative Mitral Regurgitation: 10-Year Study Confirms High Survival Rates with Surgical Repair
A decade-long study confirms excellent survival and low reoperation rates for mitral valve repair at high-volume centres.
1
Mins
21 Feb 2025
Clinical Updates on Cerliponase Alfa ▼ in Children with CLN2 Disease
This infographic details the presentation, progression, and treatment of neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a…
21 Feb 2025
New Strategy Enhances PD-1 Therapy in Treatment-Resistant Cancers
Blocking GDF-15 with visugromab enhances immune checkpoint therapy, offering new hope for resistant advanced cancers.
21 Feb 2025
Robotic Bronchoscopy Safely Diagnoses Peripheral Lung Lesions
A large, multicentre study has demonstrated that robotic-assisted bronchoscopy is both safe and effective for diagnosing small and peripheral lung lesions.
←
1
2
3
…
16
17
18
19
20
21
22
…
1,058
1,059
1,060
→